Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries
Intelligent Bio Solutions Inc. (NASDAQ: INBS) highlights the growing need for drug testing solutions in key industries such as construction, manufacturing, transport and warehousing, mining, and automotive. The company cites alarming statistics on illicit drug use among workers, including:
- 17.8% of people aged 18 or older used illicit drugs in the prior month
- 8.6% of full-time workers aged 18-64 used illicit drugs in the prior month
- 70% of employers have felt effects of prescription drug usage
- Industry-specific data shows high rates of drug use, particularly in construction (11.6%) and transportation (27.6% among truck drivers)
INBS positions its Intelligent Fingerprinting Drug Screening System as a non-invasive, efficient solution for employers to maintain safe workplaces. The company reports strong growth and expansion into new markets.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) sottolinea la crescente necessità di soluzioni per i test antidroga in settori chiave come costruzione, produzione, trasporti e magazzinaggio, estrazione mineraria e automotive. L'azienda cita statistiche preoccupanti sull'uso di droghe illegali tra i lavoratori, tra cui:
- Il 17,8% delle persone di età pari o superiore a 18 anni ha fatto uso di droghe illegali nell'ultimo mese
- L'8,6% dei lavoratori a tempo pieno di età compresa tra 18 e 64 anni ha usato droghe illegali nell'ultimo mese
- Il 70% dei datori di lavoro ha avvertito gli effetti dell'uso di farmaci prescritti
- Dati specifici di settore mostrano alti tassi di uso di droghe, in particolare nella costruzione (11,6%) e nei trasporti (27,6% tra i conducenti di camion)
INBS propone il suo Intelligent Fingerprinting Drug Screening System come una soluzione non invasiva ed efficiente per aiutare i datori di lavoro a mantenere luoghi di lavoro sicuri. L'azienda segnala una forte crescita e un'espansione in nuovi mercati.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) destaca la creciente necesidad de soluciones para pruebas de drogas en industrias clave como la construcción, la manufactura, el transporte y almacenamiento, la minería y la automoción. La empresa cita estadísticas alarmantes sobre el uso de drogas ilegales entre los trabajadores, incluyendo:
- El 17.8% de las personas mayores de 18 años usaron drogas ilegales en el último mes
- El 8.6% de los trabajadores a tiempo completo de entre 18 y 64 años usaron drogas ilegales en el último mes
- El 70% de los empleadores ha sentido los efectos del uso de medicamentos recetados
- Datos específicos de la industria muestran altas tasas de uso de drogas, particularmente en la construcción (11.6%) y en el transporte (27.6% entre los conductores de camiones)
INBS posiciona su Intelligent Fingerprinting Drug Screening System como una solución no invasiva y eficiente para que los empleadores mantengan lugares de trabajo seguros. La empresa informa sobre un fuerte crecimiento y expansión en nuevos mercados.
Intelligent Bio Solutions Inc. (NASDAQ: INBS)는 건설, 제조, 운송 및 물류, 광업, 자동차 등 주요 산업에서 약물 검사 솔루션에 대한 증가하는 필요성을 강조합니다. 회사는 근로자들 사이의 불법 약물 사용에 대한 우려스러운 통계를 인용합니다. 통계는 다음과 같습니다:
- 18세 이상의 17.8%가 지난 한 달 동안 불법 약물을 사용했습니다.
- 18세에서 64세 사이의 정규직 근로자의 8.6%가 지난 한 달 동안 불법 약물을 사용했습니다.
- 고용주의 70%가 처방약 사용의 영향을 느꼈습니다.
- 산업별 데이터는 특히 건설(11.6%)과 운송(트럭 운전사 중 27.6%)에서 높은 약물 사용 비율을 보여줍니다.
INBS는 Intelligent Fingerprinting Drug Screening System을 비침습적이고 효율적인 솔루션으로 위치시키며, 이를 통해 고용주가 안전한 작업장을 유지할 수 있도록 합니다. 이 회사는 강력한 성장과 새로운 시장으로의 확장을 보고하고 있습니다.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) souligne le besoin croissant de solutions de dépistage des drogues dans des secteurs clés tels que la construction, la fabrication, le transport et l'entreposage, l'exploitation minière et l'automobile. L'entreprise cite des statistiques alarmantes sur l'usage illicite des drogues parmi les travailleurs, y compris:
- 17,8 % des personnes âgées de 18 ans ou plus ont utilisé des drogues illicites au cours du mois précédent
- 8,6 % des travailleurs à temps plein âgés de 18 à 64 ans ont utilisé des drogues illicites au cours du mois précédent
- 70 % des employeurs ont ressenti les effets de l'utilisation de médicaments prescrits
- Des données spécifiques à l'industrie montrent des taux élevés d'utilisation de drogue, en particulier dans la construction (11,6 %) et le transport (27,6 % parmi les conducteurs de camions)
INBS positionne son système de dépistage de drogue Intelligent Fingerprinting comme une solution non invasive et efficace pour permettre aux employeurs de maintenir des lieux de travail sûrs. L'entreprise rapporte une forte croissance et une expansion sur de nouveaux marchés.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) hebt den zunehmenden Bedarf an Drogen-Testlösungen in wichtigen Branchen wie Bau, Fertigung, Transport und Lagerhaltung, Bergbau und Automobil hervor. Das Unternehmen weist auf alarmierende Statistiken über den illegalen Drogenkonsum unter Arbeitern hin, darunter:
- 17,8% der Personen im Alter von 18 Jahren oder älter haben im vergangenen Monat illegale Drogen konsumiert
- 8,6% der Vollzeitarbeiter im Alter von 18 bis 64 Jahren haben im vergangenen Monat illegale Drogen konsumiert
- 70% der Arbeitgeber haben die Auswirkungen des Verschreibungsmedikamentenverbrauchs gespürt
- Branchenspezifische Daten zeigen hohe Drogenkonsumraten, insbesondere im Bauwesen (11,6%) und im Transportwesen (27,6% unter Lkw-Fahrern)
INBS positioniert sein Intelligent Fingerprinting Drug Screening System als eine nicht-invasive, effiziente Lösung, um Arbeitgebern zu helfen, sichere Arbeitsplätze zu gewährleisten. Das Unternehmen berichtet von starkem Wachstum und Expansion in neue Märkte.
- Increasing demand for drug testing solutions in critical industries
- Company's innovative non-invasive drug testing technology addressing market needs
- Strong growth and expansion into new markets reported
- Gaining momentum with new accounts
- None.
NEW YORK, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) provides an overview of the increasing prevalence of on-the-job drug use across critical sectors such as construction, manufacturing, transport and warehousing, mining, and automotive. As the need for robust drug testing solutions intensifies, we believe that our company is positioned to lead the way in providing innovative, non-invasive drug testing technologies.
The challenges faced across these critical sectors are:
| Challenge 1: | A national survey published in 2023 on drug use and health in the U.S. by the Substance Abuse and Mental Health Services Administration (SAMHSA) reported that among people aged 18 or older, |
| Challenge 2: | A short report published in 2015 by The Substance Abuse and Mental Health Services Administration showed that an annual average of |
| Challenge 3: | Survey results published in 2017 by the National Safety Council showed that 7 in 10 employers in the U.S. have felt some effect of prescription drug usage, including near miss of injury and impaired or decreased job performance. In fact, according to the survey, |
| Challenge 4: | The same survey results published by the National Safety Council in 2017 showed that prescription drug misuse has impacted more than 70 per cent of employers in the U.S.4. |
These factors have an alarming impact on employees in industries where safety and productivity are paramount, such as the following:
| Industry | Percentage of past month illicit drug use among adults aged 18 to 64 employed full time, by industry category: combined data 2008 to 2012, as published in 2015 SAMHSA short report5. | Other data |
| Construction | ||
| Manufacturing | ||
| Transportation & Warehousing | A 2019 analysis of data found that | |
| Mining & Related | ||
| Automotive | N/A | The National Highway Safety Administration (NHSA) conducted a study using data from both oral fluid and blood samples, overall results showed 22.3 percent of daytime drivers and 22.5 percent of nighttime drivers were drug positive7. |
As awareness of the increasing prevalence of on-the-job drug use in critical sectors grows, so does the demand for effective drug testing solutions. Intelligent Bio Solutions understands the critical need for robust drug screening processes that can help businesses maintain a safe and productive work environment. Our Intelligent Fingerprinting Drug Screening System is designed to offer a non-invasive, efficient, and reliable method for employers to safeguard their workforce. Considering this growing concern, our growth remains strong, and we are gaining momentum by expanding into new markets and expanding with new accounts.
We plan to provide additional insights in the coming weeks leading up to the filing of our Annual Report on Form 10-K, along with our upcoming earnings release. For more information about our innovative drug testing solutions and how we can support your organization in maintaining a safe workplace, please contact us or visit our website at www.ibs.inc.
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is dedicated to pioneering non-invasive medical technology solutions. Our mission is to deliver innovative, reliable, and user-friendly products that enhance drug testing and screening processes, ultimately contributing to safer and healthier workplaces.
Forward-Looking Statements:
Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.’s ability to successfully develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions’ public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
LinkedIn | Twitter
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
_____________________________
1 Substance Abuse and Mental Health Services Administration (SAMHSA). (2023). 2023 National Survey on Drug Use and Health (NSDUH) releases. Available at: https://www.samhsa.gov/data/release/2023-national-survey-drug-use-and-health-nsduh-releases
2 Bush, D.M. and Lipari, R.N. (2015). Substance Use and Substance Use Disorder by Industry. Available at: https://www.samhsa.gov/data/sites/default/files/report_1959/ShortReport-1959.html
3 National Safety Council. (2017). National employer drug survey results. Available at: https://www.nsc.org/getmedia/ee37d83e-486c-4869-b63d-275413fa767d/national-employer-drug-survey-results.pdf
4 National Safety Council. (2017). National employer drug survey results. Available at: https://www.nsc.org/getmedia/ee37d83e-486c-4869-b63d-275413fa767d/national-employer-drug-survey-results.pdf
5 Bush, D.M. and Lipari, R.N. (2015). Substance Use and Substance Use Disorder by Industry. Available at: https://www.samhsa.gov/data/sites/default/files/report_1959/ShortReport-1959.html
6 Dini, G., Bragazzi, N. L., Montecucco, A., Rahmani, A., & Durando, P. (2019). Psychoactive drug consumption among truck-drivers: a systematic review of the literature with meta-analysis and meta-regression. Journal of preventive medicine and hygiene, 60(2), E124–E139. https://doi.org/10.15167/2421-4248/jpmh2019.60.2.1245
7 National Highway Traffic Safety Administration (NHTSA). (2017). National roadside survey of alcohol and drug use by drivers. Available at: https://www.nhtsa.gov/sites/nhtsa.gov/files/documents/13013-nrs_drug_092917_v6_tag.pdf
FAQ
What industries are facing challenges with on-the-job drug use according to INBS?
What percentage of full-time workers aged 18-64 used illicit drugs according to the INBS press release?
How does Intelligent Bio Solutions Inc. (INBS) address the drug testing needs in the market?
What percentage of truck drivers were found to consume drugs according to the INBS press release?
